ArticleBritish journal of cancer2009

Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.

X Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.